Journey II
Payments companies reported to CMS as associated with Journey II. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Journey II, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Journey II
These are the largest totals companies reported as associated with Journey II. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Steven Haas | New York, NY | Orthopaedic Surgery | $3,731,385.36 |
| Jonathan Garino | Malvern, PA | Orthopaedic Surgery | $2,942,434.74 |
| Michael Ries | Reno, NV | Adult Reconstructive Orthopaedic Surgery | $2,761,515.30 |
| Fred Cushner | New York, NY | Orthopaedic Surgery | $1,176,735.50 |
| Thorsten Seyler | Durham, NC | Adult Reconstructive Orthopaedic Surgery | $912,146.42 |
| Kevin Fricka | Alexandria, VA | Adult Reconstructive Orthopaedic Surgery | $803,863.36 |
| Hany Bedair | Chicago, IL | Adult Reconstructive Orthopaedic Surgery | $750,073.38 |
| Ran Schwarzkopf | Orange, CA | $704,072.14 | |
| James Chow | Phoenix, AZ | Orthopaedic Surgery | $674,327.45 |
| John Barrington | Plano, TX | Adult Reconstructive Orthopaedic Surgery | $657,950.63 |
Prescribed Journey II?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.